MarketCap
Facebook
X
TelegramQuarterly report 2024-Q4
added 01-10-2025
Accolade Retained Earnings 2011-2025 | ACCD
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Accolade
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -372 M | -321 M | -270 M | -213 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -213 M | -372 M | -294 M |
Quarterly Retained Earnings Accolade
| 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.23 B | -1.11 B | -1.08 B | -1.05 B | -1.05 B | -1.03 B | -993 M | -954 M | -924 M | -884 M | -837 M | -495 M | -460 M | -483 M | -420 M | -372 M | -367 M | -350 M | -335 M | -321 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -321 M | -1.23 B | -737 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
-606 M | $ 4.11 | -0.48 % | $ 385 M | USA |
 |
Health Catalyst
HCAT
|
-1.19 B | $ 2.34 | -4.82 % | $ 141 M | USA |
 |
HealthStream
HSTM
|
109 M | $ 24.4 | 0.95 % | $ 741 M | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
-67.7 M | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
206 M | $ 96.06 | -0.75 % | $ 8.22 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 13.18 | -1.35 % | $ 226 M | USA |
 |
American Well Corporation
AMWL
|
-1.97 B | $ 4.68 | 1.3 % | $ 70.2 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
Progyny
PGNY
|
144 M | $ 26.39 | -1.2 % | $ 2.26 B | USA |
 |
Premier
PINC
|
-485 M | $ 28.26 | - | $ 2.33 B | USA |
 |
MTBC
MTBC
|
-66.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.72 | -3.72 % | $ 1.05 B | USA |
 |
Schrödinger
SDGR
|
-526 M | $ 18.41 | 1.99 % | $ 1.34 B | USA |
 |
Omnicell
OMCL
|
383 M | $ 43.31 | -1.25 % | $ 1.99 B | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
Phreesia
PHR
|
-743 M | $ 16.68 | 2.71 % | $ 910 M | USA |
 |
So-Young International
SY
|
-926 M | $ 2.92 | -5.66 % | $ 232 M |  China |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 15.77 | 2.01 % | $ 1.85 B | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
Veeva Systems
VEEV
|
2.74 B | $ 219.17 | -1.81 % | $ 35.2 B | USA |
 |
Zhongchao
ZCMD
|
-7.96 M | $ 0.58 | -3.18 % | $ 3.02 M | China |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-16.2 B | $ 7.36 | -2.65 % | $ 1.26 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
SCWorx Corp.
WORX
|
-31 M | $ 0.21 | 5.86 % | $ 306 K | USA |